GlaxoSmithKline Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹1,183.57 crore and net profit of ₹335.88 crore
- Revenue rose 20.8% year on year; operating margin was approximately 32.7%.
- Net profit increased 30.4% year on year; no exceptional items were recorded, and the limited-review conclusions were unmodified.
- Appointed Sandeep Seth as Head of Ethics & Compliance.
- Approved Walker Chandiok & Co LLP as statutory auditors for FY28–FY32, subject to shareholder approval.